Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.
Slovin SF, Scher HI, Divgi CR, Reuter V, Sgouros G, Moore M, Weingard K, Pettengall R, Imbriaco M, El-Shirbiny A, Finn R, Bronstein J, Brett C, Milenic D, Dnistrian A, Shapiro L, Schlom J, Larson SM.
Slovin SF, et al. Among authors: dnistrian a.
Clin Cancer Res. 1998 Mar;4(3):643-51.
Clin Cancer Res. 1998.
PMID: 9533532